Prevalence of mutations in the alpha 1 antitrypsin gene in patients with pulmonary emphysema

E. Laviña Soriano (Guadalajara, Spain), F. Muñiz (Madrid, Spain), M. Castillo García (Guadalajara, Spain), D. Morena Vallés (Guadalajara, Spain), A. Ampuero López (Guadalajara, Spain), J. Izquierdo Alonso (Guadalajara, Spain), J. Rodríguez Gonzalez Moro (Madrid, Spain)

Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions
Session: Chronic cough, a1-antitrypsin deficiency and other conditions
Session type: Thematic Poster
Number: 4355
Disease area: -

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Laviña Soriano (Guadalajara, Spain), F. Muñiz (Madrid, Spain), M. Castillo García (Guadalajara, Spain), D. Morena Vallés (Guadalajara, Spain), A. Ampuero López (Guadalajara, Spain), J. Izquierdo Alonso (Guadalajara, Spain), J. Rodríguez Gonzalez Moro (Madrid, Spain). Prevalence of mutations in the alpha 1 antitrypsin gene in patients with pulmonary emphysema. 4355

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Initial values of alpha 1 antitrypsin and transferrin in patients with pulmonary tuberculosis
Source: Eur Respir J 2007; 30: Suppl. 51, 660s
Year: 2007

Reduction in incidence of exacerbations in patients with alpha 1 antitrypsin deficiency (A1ATD) treated with concentrates of alpha 1 antitrypsin (A1AT): REXA study
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011


A new SERPINA-1 missense mutation associated with alpha-1 antitrypsin deficiency and bronchiectasis.
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017


Alpha 1 antitrypsin (A1AT) deficiency among patients with cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 501s
Year: 2003

Patterns of exacerbations in alpha 1 antitrypsin deficiency (AATD)
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Endobronchial valve treatment in patients with severe emphysema due to alpha-1 antitrypsin deficiency.
Source: International Congress 2019 – Interventional pulmonology: diagnostic techniques and obstructive airway disease
Year: 2019

Association between alpha 1 antitrypsin and bronchiectasis
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015

Identification of a novel SERPINA-1 mutation causing alpha-1 antitrypsin deficiency in a patient with severe dyspnea
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016


GSTP1 polymorphisms in patients with COPD and alpha-1 antitrypsin deficiency
Source: Eur Respir J 2003; 22: Suppl. 45, 384s
Year: 2003

Prevalence of alpha-1 antitrypsin deficiency (AATD) and frequencies of alleles PI*S and PI*Z in patients with COPD in Brazil
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013

Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patients
Source: Annual Congress 2011 - Lung development and neoplasia
Year: 2011

Alpha 1 antitrypsin deficiency prevalence measured by genetic testing with salivary swab in patients with chronic airway obstruction
Source: Virtual Congress 2020 – Challenges and updates in nursing care around the world
Year: 2020


Screening for α1-Pi deficiency in patients with lung diseases
Source: Eur Respir J 2002; 20: 319-324
Year: 2002



Comparison of outcomes in augmentation naïve and augmented patients with alpha-1 antitrypsin deficiency related lung disease.
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Year: 2019


The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes
Source: Eur Respir J, 56 (6) 2001441; 10.1183/13993003.01441-2020
Year: 2020



Screening of chronic liver disease by transient elastography in patients with lung disease associated with alpha-1 antitrypsin deficiency.
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018


Polymorphisms of the beta adrenoceptor are associated with severity of disease, but not disease susceptibility, in subjects with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 378s
Year: 2002

Clinical features of alpha one antitrypsin deficiency in COPD
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012

Clinical features of alpha one antitrypsin deficiency in non cystic fibrosis bronchiectasis
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012

COPD in individuals with the PiMZ alpha-1 antitrypsin genotype
Source: Eur Respir Rev, 26 (146) 170068; 10.1183/16000617.0068-2017
Year: 2017